Anixa Doesn't Disappoint
Source: Daniel Carlson for Streetwise Reports  (1/29/19)
Daniel Carlson of Tailwinds Research explains why he has designated this company his 2019 stock of the year. More >

Early Data for Biotech's Pain Drug Candidate 'Show Promise'
Source: Streetwise Reports  (1/26/19)
An H.C. Wainwright & Co. report reviewed Phase 1b data for this nonopioid medication being developed for patients with severe pain. More >

Commercial Launch Planned for Schizophrenia Drug
Source: Streetwise Reports  (1/23/19)
A drug used to treat schizophrenic patients will launch commercially in February in the U.S. More >

Analyst: Reaction to Trial Data 'Unwarranted'
Source: Streetwise Reports  (1/23/19)
An analyst's note reviewed the recently announced study results in pancreatic cancer as well as the subsequent decline in stock price. More >

Analyst Shares 'Revelations from a Pooled Safety Analysis' of Pain Drug
Source: Streetwise Reports  (1/23/19)
An H.C. Wainwright & Co. report discussed the analgesic's safety profile and how it compares to an on-the-market competitor. More >

Phase 2 Study Begins for German Biopharma's Cancer Drug Candidate
Source: Streetwise Reports  (1/16/19)
A LifeSci Capital report discussed two current trials in which this therapeutic is being evaluated. More >

Biotech's Flu Vaccine Shows 'Superiority to Market Leader' in Data
Source: Streetwise Reports  (1/11/19)
Study findings that differentiate this product from competitors were reviewed in a Ladenburg Thalmann research report. More >

Biotech Enters License Agreement to Validate Biomarker as Alternative NASH Diagnostic
Source: Streetwise Reports  (1/5/19)
The background and justification for the deal was covered in an H.C. Wainwright & Co. report. More >

Potential Tenbagger Biopharma Displays 'Strong Start to New Year'
Source: Streetwise Reports  (1/4/19)
A ROTH Capital Partners report discussed the recent trial launch and provided upcoming catalysts for the stock. More >

Texas-Based Biopharma Gets PDUFA Date for Lead Orphan Disease Asset
Source: Streetwise Reports  (1/2/19)
An H.C. Wainwright & Co. report covered the potential timeline to market and subsequent estimated revenue for this therapeutic, which addresses a rare disorder in collagen production. More >

Coverage Initiated on Pharma 'Leveraging Large Markets with Differentiated Products'
Source: Streetwise Reports  (12/29/18)
A Ladenburg Thalmann report outlined the investment thesis for this Colorado-based life sciences firm. More >

Therapeutics Developer Secures Patents, Continues Phase 3 Trial Planning
Source: Streetwise Reports  (12/24/18)
An H.C. Wainwright & Co. report provided an update on the Q3/18 activities and achievements of this company targeting NASH. More >

Coverage Initiated on Vaccine Developer with 'Transformational' Data Expected
Source: Streetwise Reports  (12/24/18)
A Ladenburg Thalmann report discussed this biotech's late-stage clinical assets in RSV and influenza. More >

Analyst: Biopharma Makes 'Right Call' in Stopping Combination Agent in Trial
Source: Streetwise Reports  (12/19/18)
A Mackie Research Capital Corp. note reviewed recent and upcoming developments in this immunotherapy developer's clinical study. More >

Small-Cap Firm Announces Major Medical Technology Acquisition
Source: Ron Struthers for Streetwise Reports  (12/17/18)
Ron Struthers of Struthers Resource Stock Report profiles an innovative medical firm in Canada that just announced the acquisition of a medical technology firm, a move that will expand its reach across Canada. More >

Biotech Delivers Positive Study Results for Prostate Cancer Prognostic Test
Source: Streetwise Reports  (12/5/18)
An H.C. Wainwright & Co. report reviewed this firm's latest news concerning a data readout, trial approval and therapeutic application. More >

Precision Medicine Developer Secures Another Patent for Drug Candidate
Source: Streetwise Reports  (12/5/18)
This company takes a step forward in its efforts to protect its intellectual property. More >

Biotech to Lead dMAB Tech Field with First Clinically Tested Product
Source: Streetwise Reports  (11/28/18)
An H.C. Wainwright & Co. report discussed recent articles covering results of this firm's preclinical studies. More >

Cannabis Provider to Debut Five More Dispensaries in Florida
Source: Streetwise Reports  (11/26/18)
This company plans to add even more this year as well. More >

Biopharma Agrees to $215 Million Acquisition Deal
Source: Streetwise Reports  (11/21/18)
An H.C. Wainwright & Co. report detailed the terms of the definitive agreement concerning the merger. More >

Biopharma to Accelerate Trial Timeline with Amendment
Source: Streetwise Reports  (11/21/18)
The change relates to the onset of dosing for patients with different degrees of disease. More >

Biotech Ramps Up Philippine Sales of Livestock Feed Premix
Source: Streetwise Reports  (11/21/18)
A distributor of the proprietary product places a third large order. More >

Life Science Company Addresses Antibiotic Resistance Problem
Source: Streetwise Reports  (11/18/18)
This firm's proprietary technology provides an alternative to antibiotic use in livestock production. More >

Biotech Files Patent Application for Nitric Oxide Delivery Device
Source: Streetwise Reports  (11/16/18)
With this development, the company advances blood/plasma transfusion technology.
More >

Imprimis: Priming the Pumps for a Big 2019
Source: Daniel Carlson for Streetwise Reports  (11/15/18)
Daniel Carlson of Tailwinds Research profiles a biotech company he is bullish on. More >